| Recruiting | AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond Metastatic Colorectal Cancer (mCRC) | — | 2024-10-31 |
| Recruiting | AGMT Austrian Lymphoma Registry Lymphoma | — | 2024-02-27 |
| Recruiting | AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry Chronic Lymphocytic Leukemia | — | 2022-03-24 |
| Active Not Recruiting | Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM Newly Diagnosed Multiple Myeloma | Phase 2 | 2021-10-20 |
| Recruiting | Lung Cancer Registry Lung Cancer, NSCLC Stage IV, NSCLC, Stage III | — | 2020-08-18 |
| Recruiting | Austrian Myeloid Registry Myeloid Diseases | — | 2020-07-13 |
| Unknown | Austrian COVID-19 Registry Infectious Disease, COVID-19 | — | 2020-04-01 |
| Completed | Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Adv Pancreatic Cancer Non-resectable, Chemotherapy-induced Nausea and Vomiting, Pancreatic Cancer Metastatic | Phase 3 | 2019-12-16 |
| Completed | Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients Multiple Myeloma | Phase 2 | 2019-09-30 |
| Completed | Genomic Testing and Resulting Medical Decisions Cancer of Unknown Origin, Cancer Refractory, Cancer of Stomach | — | 2017-03-30 |
| Completed | Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-m Multiple Myeloma | Phase 2 | 2017-03-10 |
| Terminated | Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck Squamous Cell Carcinoma of the Hypopharynx Stage III, Squamous Cell Carcinoma of the Hypopharynx Stage IV, Laryngeal Squamous Cell Carcinoma Stage III | Phase 3 | 2017-02-03 |
| Completed | Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL Lymphoma, Large B-Cell, Diffuse | Phase 2 | 2017-01-04 |
| Terminated | Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Ca Triple-Negative Breast Cancer | Phase 1 / Phase 2 | 2016-11-21 |
| Terminated | Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK+ ALCL ALK+ Anaplastic Large Cell Lymphoma | Phase 1 / Phase 2 | 2015-11-03 |
| Recruiting | Metastatic Breast Cancer in Austria Breast Cancer, Breast Carcinoma, Breast Tumor | — | 2015-06-15 |
| Completed | Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Multiple Myeloma | Phase 2 | 2015-04-01 |
| Completed | Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir HIV Infections | Phase 2 | 2014-05-01 |
| Completed | Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving Chronic Phase Chronic Myeloid Leukemia | Phase 1 | 2013-08-30 |
| Completed | Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cance Breast Cancer | Phase 2 | 2013-08-09 |
| Completed | Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Squamous Cell Carcinoma of the Hypopharynx Stage III, Squamous Cell Carcinoma of the Hypopharynx Stage IV, Squamous Cell Carcinoma of the Larynx Stage III | Phase 2 | 2013-05-01 |
| Completed | Biomarker Directed Treatment in Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2012-12-04 |
| Completed | Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL CLL, Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | 2012-06-01 |
| Completed | Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) | Phase 2 | 2012-05-01 |
| Completed | Pharmacokinetics and Metabolic Activation of Capecitabine Metastatic Colorectal Cancer | Phase 2 | 2012-02-01 |
| Completed | Exercise Training in Postmenopausal Patients With Breast Cancer Physical Activity | N/A | 2011-06-01 |
| Unknown | Lenalidomide in Patients With Chronic Myelomonocytic Leukemia Chronic Myelomonocytic Leukemia | Phase 1 / Phase 2 | 2010-06-01 |
| Completed | Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) NSCLC | Phase 2 | 2010-04-01 |
| Completed | Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leuke Chronic Lymphocytic Leukemia | Phase 3 | 2009-12-01 |
| Terminated | Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma Peripheral T-Cell Non-Hodgkin's Lymphoma | Phase 1 / Phase 2 | 2009-09-01 |
| Completed | Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metasta Gastric Cancer, Unresectable | Phase 2 | 2009-07-01 |
| Terminated | Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Ther Metastatic Breast Cancer | Phase 2 | 2009-05-01 |
| Completed | Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL) Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 / Phase 2 | 2009-03-01 |
| Completed | Registry on Hypomethylating Agents in Myeloid Neoplasms Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Acute Myeloid Leukemia | — | 2009-02-09 |
| Completed | Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 / Phase 2 | 2008-10-01 |
| Terminated | Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma Esophageal Cancer | Phase 2 | 2008-08-01 |
| Completed | Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Lymphoma of Mucosa-Associated Lymphoid Tissue | Phase 2 | 2008-05-01 |
| Completed | Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large Diffuse Large B-Cell Lymphoma | Phase 2 | 2007-12-01 |
| Completed | A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients Diffuse Large B-Cell Lymphoma (DLBCL), Follicular NHL Grade 3b | Phase 3 | 2006-01-01 |
| Completed | A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Eff B-cell Chronic Lymphocytic Leukemia | Phase 2 | 2004-03-01 |
| Completed | Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therap Follicular T-NHL Lymphoma, Rituximab Maintenance | Phase 2 | 2004-01-01 |
| Terminated | Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wi KRAS Wild Type, Resectable Type II Gastric Adenocarcinoma | Phase 2 | — |
| No Longer Available | Dose-Dense Therapy in Aggressive Lymphoma Lymphoma | — | — |